pLentiCrispr-V2-mOrange (V2mO) Citations (2)

Originally described in: An improved strategy for CRISPR/Cas9 gene knockout and subsequent wildtype and mutant gene rescue.
Jin J, Xu Y, Huo L, Ma L, Scott AW, Pizzi MP, Li Y, Wang Y, Yao X, Song S, Ajani JA PLoS One. 2020 Feb 13;15(2):e0228910. doi: 10.1371/journal.pone.0228910. eCollection 2020. PubMed Journal

---

Articles Citing pLentiCrispr-V2-mOrange (V2mO)

Articles
A Hotspot Phosphorylation Site on SHP2 Drives Oncoprotein Activation and Drug Resistance. Karunaraj P, Scheele R, Wells ML, Rathod R, Abrahamson S, Taylor LC, Gokulu IS, Chowdhury L, Kazmi A, Song W, Hornbeck P, Li J, Glasgow A, Vasan N. bioRxiv [Preprint]. 2025 Jun 16:2025.06.11.659120. doi: 10.1101/2025.06.11.659120. PubMed
A Hotspot Phosphorylation Site on SHP2 Drives Oncoprotein Activation and Drug Resistance. Karunaraj P, Scheele R, Wells ML, Rathod R, Gokulu IS, Abrahamson S, Taylor L, Chowdhury L, Kazmi A, Song W, Hornbeck P, Li J, Glasgow A, Vasan N. Res Sq [Preprint]. 2025 Aug 5:rs.3.rs-7032881. doi: 10.21203/rs.3.rs-7032881/v1. PubMed

If you have published an article using this material, please email us at to have your article added to this page.